Metraipolis › archive › dc_fdf633757d86

Efficacy and safety of maribavir in Japanese patients with post-transplant cytomegalovirus infections: a phase III study — Europe PMC PMID:42283791

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42283791
DOI
10.1007/s12185-[numero omesso]-3
License (as archived)
solo-consultazione
Archived
2026-10-31T12:49:36.819Z
SHA-256 of the archived text
0813438b00e72a76a0ccc895f9db4ab4ad94bb8a582c0f6542b61d001a36e9d8
Stable URL of this page
https://metraipolis.com/documento/dc_fdf633757d86

How to cite

Efficacy and safety of maribavir in Japanese patients with post-transplant cytomegalovirus infections: a phase III study — Europe PMC PMID:42283791 — Europe PMC (en), https://europepmc.org/article/MED/42283791 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fdf633757d86 (Metraipolis archive dc_fdf633757d86, sha256 0813438b00e72a76a0ccc895f9db4ab4ad94bb8a582c0f6542b61d001a36e9d8)
BibTeX
@misc{dcfdf633757d86,
  title = {Efficacy and safety of maribavir in Japanese patients with post-transplant cytomegalovirus infections: a phase III study — Europe PMC PMID:42283791},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42283791},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fdf633757d86; sha256 0813438b00e72a76a0ccc895f9db4ab4ad94bb8a582c0f6542b61d001a36e9d8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42283791. Agents can read the archived copy with the MCP tool read_document.